Literature DB >> 16080422

The use of psychostimulants in pervasive developmental disorders.

Patricia Karen Abanilla1, Greg A Hannahs, Robyn Wechsler, Raul R Silva.   

Abstract

Many children with Pervasive Developmental Disorders (PDD) display problematic behaviors similar to those seen in children with Attention Deficit Hyperactivity Disorder (ADHD). This paper will look at the controversy concerning diagnosing comorbid ADHD in children who meet criteria for PDD and review the existing literature examining the efficacy of stimulants in these particular set of behaviors or symptom clusters (hyperactivity, impulsivity and inattention). The potential drawbacks of using stimulants in a population of children and adolescents who exhibit symptoms of PDD and ADHD will be discussed. Finally, this review will also attempt to define potential areas of future research to examine the utility of the psychostimulants in children and adolescents with PDD and symptoms of ADHD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16080422     DOI: 10.1007/s11126-005-2980-7

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  24 in total

1.  How unspecified are disorders of children with a pervasive developmental disorder not otherwise specified? A study of social problems in children with PDD-NOS and ADHD.

Authors:  E F Luteijn; M Serra; S Jackson; M P Steenhuis; M Althaus; F Volkmar; R Minderaa
Journal:  Eur Child Adolesc Psychiatry       Date:  2000-09       Impact factor: 4.785

2.  Randomized trial of methylphenidate for an autistic child.

Authors:  J M Strayhorn; N Rapp; W Donina; P S Strain
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1988-03       Impact factor: 8.829

3.  Methylphenidate treatment of hyperactive autistic children.

Authors:  B Birmaher; H Quintana; L L Greenhill
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1988-03       Impact factor: 8.829

4.  Coexistence of childhood onset pervasive developmental disorder and attention deficit disorder with hyperactivity.

Authors:  B Geller; L B Guttmacher; M Bleeg
Journal:  Am J Psychiatry       Date:  1981-03       Impact factor: 18.112

5.  Levodopa and levoamphetamine: a crossover study in young schizophrenic children.

Authors:  M Campbell; A M Small; P J Collins; E Friedman; R David; N Genieser
Journal:  Curr Ther Res Clin Exp       Date:  1976-01

6.  Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.

Authors:  B L Handen; A M Breaux; A Gosling; D L Ploof; H Feldman
Journal:  Pediatrics       Date:  1990-12       Impact factor: 7.124

7.  A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders.

Authors:  Kimberly A Stigler; Lael A Desmond; David J Posey; Ryan E Wiegand; Christopher J McDougle
Journal:  J Child Adolesc Psychopharmacol       Date:  2004       Impact factor: 2.576

8.  Differentiating attention-deficit/hyperactivity disorder from pervasive developmental disorder not otherwise specified.

Authors:  H Roeyers; H Keymeulen; A Buysse
Journal:  J Learn Disabil       Date:  1998 Nov-Dec

9.  Problem behavior and psychiatric impairment within a developmentally disabled population I: behavior frequency.

Authors:  J W Jacobson
Journal:  Appl Res Ment Retard       Date:  1982

10.  Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD.

Authors:  Deborah A Pearson; Cynthia W Santos; Charles D Casat; David M Lane; Susan W Jerger; John D Roache; Katherine A Loveland; David Lachar; Laura P Faria; Christa D Payne; Lynne A Cleveland
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-06       Impact factor: 8.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.